By Chris MasonPolitical editor, BBC News “We cannot keep dealing with this horrific meltdown of ...
By Fergus WalshMedical editor Artificial intelligence is nearly twice as good at grading the aggressiveness ...
EPA By Farai SevenzoHarare For months now, Zimbabwe has been battling to stem the spread ...
Pictured: Money growth/iStock, RomoloTavani The current environment for big and small biotechs has been harrowing over ...
Pictured: GSK laboratories in Dresden, Germany/iStock, 13threephotography In its third-quarter earnings report posted Wednesday, GSK ...
Pictured: AstraZeneca production plant/iStock, Roland Magnusson A lucrative collaboration agreement with AstraZeneca sent Cellectis shares ...
Pictured: Three doctors holding their thumbs up/iStock, andrei_r The FDA’s Cellular, Tissue, and Gene Therapies Advisory ...
Estimates of clinical trial participation among eligible patients have remained at less than five percent ...
Pictured: Multiple sets of hands push puzzle pieces together/iStock, Lacheev Biotech funding is not great ...
Pictured: A researcher at work in a Novavax laboratory/Novavax, Patrick Siebert Combination vaccines are nothing ...